Featured
Digital Therapeutics App for ADHD Receives FDA De Novo Clearance as Non-Stimulant Alternative
The FDA has granted De Novo clearance to FocusFlow, a prescription digital therapeutic for pediatric ADHD. Utilizing gamified CBT and EEG neurofeedbac...
Read Full Story →